한글목차

바이오칩 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 146억 1,000만 달러에서 2026년에는 169억 7,000만 달러로, CAGR 16.1%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 유전체학 및 단백질체학 연구의 발전, 제약 및 생명공학 분야의 R&D 프로그램 확대, 유전자 스크리닝에 DNA 마이크로어레이 도입, 분자진단에 바이오칩 활용 확대, 마이크로어레이 및 마이크로플루이딕스 기술 기반 분석 플랫폼의 개발에 기인한 것으로 보입니다.

바이오칩 시장 규모는 향후 수년간 급성장이 전망되고 있습니다. 2030년에는 290억 3,000만 달러에 달하며, CAGR은 14.4%로 예측되고 있습니다. 예측 기간 중의 성장 요인으로는 정밀의료 및 맞춤치료에 대한 수요 증가, 임상 검사에서 랩온칩 기술의 활용 확대, 바이오마커 발굴 및 중개연구에 대한 투자 증가, 농업 및 생명과학 분야에서의 바이오칩 적용 범위 확대, 첨단 바이오칩 기반 진단 툴의 상용화에 대한 기대감 등이 있습니다. 바이오칩 기반 진단 툴의 상용화 진전 등을 들 수 있습니다. 예측 기간 중 주요 동향으로는 유전자 염기서열 분석 및 질병 진단을 위한 바이오칩 채택 확대, 첨단 생체 분자 연구를 위한 단백질 및 세포 어레이의 사용 증가, POC(Point-Of-Care) 검사에서 랩온칩 플랫폼에 대한 수요 증가, 신약 개발 분야에서의 바이오칩 적용 확대, 소형화 및 고처리량 생물학적 데이터 분석에 대한 관심 증가 등이 있습니다. 소형화 및 고처리량 생물학적 데이터 분석에 대한 집중 등을 들 수 있습니다.

바이오칩 시장은 맞춤형 의료의 보급 확대에 따라 성장이 예상됩니다. 맞춤형 의료는 유전정보, 생활습관 등 개인 특성에 따라 치료법을 최적화하여 효과를 극대화하고 부작용을 최소화하는 것을 목적으로 하는 의료 형태입니다. 이러한 추세는 맞춤형 의료가 보다 효과적인 치료를 제공할 수 있는 가능성, 유전체학의 발전, 질병의 복잡성, 규제적 지원 등에 힘입어 더욱 가속화되고 있습니다. 바이오칩은 개인의 유전자 프로파일을 기반으로 정밀하고 맞춤 치료 계획을 가능하게 함으로써 맞춤형 의료에서 중요한 역할을 할 수 있습니다. 예를 들어 2024년 2월 FDA가 2023년 희귀질환에 대한 16건의 신규 개인맞춤형 치료제를 승인한 것은 맞춤형 의료의 도입이 가속화되고 바이오칩 시장에 영향을 미치고 있음을 보여줍니다.

바이오칩 시장의 주요 기업은 신약개발 및 개발 프로세스를 혁신하는 '장기 칩' 플랫폼 등 첨단 기술 개발에 집중하고 있습니다. 장기 칩 플랫폼은 인간 장기의 생리적 특성과 기능을 마이크로스케일로 재현하도록 설계된 첨단 마이크로플루이딕스 장치입니다. 예를 들어 2024년 4월 보스턴 마이크로패브리케이션(BMF)은 생체 외 대규모 조직 배양에 특화된 바이오칩/장기 칩 플랫폼을 제공하는 BMF 바이오테크놀러지를 설립했습니다. 이 발전은 인체 외 시험 및 연구 플랫폼을 제공하여 의약품 및 화장품 개발을 가속화할 것으로 예측됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Biochips are compact devices containing an assortment of biological substances such as DNA, proteins, or cells, affixed onto a solid surface. They merge biological components with electronic systems for studying and manipulating biological data, finding extensive use in medical diagnostics, genetic sequencing, and other biotechnological domains.

The primary types of biochips include DNA chips (or DNA microarrays), protein chips, lab-on-chip systems, tissue arrays, and cell arrays. DNA chips allow the simultaneous analysis of numerous genes' expressions, leveraging technologies such as microarrays and microfluidics. These biochips find applications in drug discovery, agriculture, genomics, disease diagnostics, proteomics, and are utilized by diverse end users such as biotech firms, pharmaceutical companies, academic institutions, hospitals, and diagnostic centers.

Tariffs are affecting the biochips market by increasing the cost of semiconductor substrates, microfluidic components, biosensor electronics, and assay reagents that rely on global manufacturing and cross-border supply chains, leading to higher production and procurement costs. The impact is more pronounced across dna chips, protein chips, and lab-on-chip platforms manufactured in Asia-Pacific and European hubs where imports of specialty materials and precision components are tariff sensitive. Biotechnology and pharmaceutical companies, academic and research institutes, and hospital diagnostic centers are experiencing extended purchasing cycles and pricing pressures due to tariff-driven cost pass-throughs. However, tariffs are also encouraging localized fabrication, regional component sourcing, and domestic biochip assembly initiatives that may strengthen supply resilience and stimulate long-term innovation investment.

The biochips market research report is one of a series of new reports from The Business Research Company that provides biochips market statistics, including biochips industry global market size, regional shares, competitors with a biochips market share, detailed biochips market segments, market trends and opportunities, and any further data you may need to thrive in the biochips industry. This biochips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biochips market size has grown rapidly in recent years. It will grow from $14.61 billion in 2025 to $16.97 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to growth in genomics and proteomics research, expansion of pharmaceutical and biotech r&d programs, adoption of dna microarrays in genetic screening, increasing use of biochips in molecular diagnostics, development of microarray and microfluidic-based analytical platforms.

The biochips market size is expected to see rapid growth in the next few years. It will grow to $29.03 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to rising demand for precision medicine and personalized therapies, growing utilization of lab-on-chip technologies in clinical testing, higher investment in biomarker discovery and translational research, expanding applications of biochips in agriculture and life sciences, increasing commercialization of advanced biochip-based diagnostic tools. Major trends in the forecast period include growing adoption of biochips in genetic sequencing and disease diagnostics, increasing use of protein and cell arrays for advanced biomolecular research, rising demand for lab-on-chip platforms in point-of-care testing, expansion of biochip applications in drug discovery and development, focus on miniaturization and high-throughput biological data analysis.

The biochips market is poised for growth due to the increasing adoption of personalized medicines. Personalized medicine involves tailoring medical treatments based on individual characteristics such as genetics or lifestyle, aiming to optimize effectiveness and minimize adverse effects. This trend is fueled by the potential of personalized medicine to offer more effective treatments, advancements in genomics, the rising complexity of diseases, and regulatory backing. Biochips play a crucial role in personalized medicine by enabling precise and individualized treatment plans based on a person's genetic profile. For instance, in February 2024, the FDA approved 16 novel personalized therapies for rare diseases in 2023, highlighting the momentum in personalized medicine adoption and its impact on the biochips market.

Leading companies in the biochips market are focusing on developing cutting-edge technologies such as organ-on-a-chip platforms to transform drug discovery and development processes. Organ-on-a-chip platforms are sophisticated microfluidic devices designed to mimic the physiological characteristics and functions of human organs on a smaller scale. For example, in April 2024, Boston Micro Fabrication (BMF) launched BMF Biotechnology Inc., specializing in biochips or organ-on-a-chip platforms for cultivating large-scale tissues in vitro. This advancement accelerates drug and cosmetic development by providing a testing and research platform outside the human body.

In June 2023, Randox Laboratories acquired Cellix Limited to bolster its expertise in benchtop flow cytometry, aligning with its commitment to personalized medicine and improved preventive healthcare. This acquisition expands Randox's portfolio and makes flow cytometry technology more accessible to a wider range of researchers and healthcare professionals. Cellix Limited, based in Ireland, specializes in creating biochips for various applications in the life sciences.

Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

North America was the largest region in the biochips market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biochips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biochips market consists of sales of lab-on-a-chip (LOC) devices, cellular microarrays, and protein microarrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biochips Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biochips market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biochips ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biochips market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Deoxyribonucleic Acid (DNA) Chips; Protein Chips; Lab-On-Chip; Tissue Arrays; Cell Arrays
• 2) By Technology: Microarrays; Microfluidics
• 3) By Application: Drug Discovery And Development; Agriculture; Genomics; Disease Diagnostics; Proteomics; Other Applications
• 4) By End-User: Biotechnology And Pharmaceutical Companies; Academic And Research Institutes; Hospitals And Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips; Snp (Single Nucleotide Polymorphism) Chips; Dna Microarrays
• 2) By Protein Chips: Antibody Arrays; Protein Microarrays; Peptide Arrays
• 3) By Lab-On-Chip: Microfluidic Devices; Biosensors
• 4) By Tissue Arrays: Tumor Tissue Arrays; Normal Tissue Arrays
• 5) By Cell Arrays: Cell-Based Biochips; Cell Signaling Arrays
• Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics International Ltd; Agilent Technologies Inc.; PerkinElmer Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Tecan Group Ltd.; Cepheid Inc.; Randox Laboratories Ltd.; Takara Bio Inc.; Luminex Corporation; Fluidigm Corporation; Micronit Microtechnologies B.V.; Sphere Fluidics Limited; Sengenics; Arrayit Corporation; CustomArray Inc.; NanoCellect Biomedical Inc.; Dolomite Microfluidics; Biocartis NV
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Biochips Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Biochips Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Biochips Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Biochips Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Growing Adoption Of Biochips In Genetic Sequencing And Disease Diagnostics
  • 4.2.2 Increasing Use Of Protein And Cell Arrays For Advanced Biomolecular Research
  • 4.2.3 Rising Demand For Lab-On-Chip Platforms In Point-Of-Care Testing
  • 4.2.4 Expansion Of Biochip Applications In Drug Discovery And Development
  • 4.2.5 Focus On Miniaturization And High-Throughput Biological Data Analysis

5. Biochips Market Analysis Of End Use Industries

• 5.1 Biotechnology And Pharmaceutical Companies
• 5.2 Academic And Research Institutes
• 5.3 Hospitals And Diagnostic Centers
• 5.4 Contract Research Organizations
• 5.5 Public Health And Genomic Research Agencies

6. Biochips Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biochips Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Biochips PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Biochips Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Biochips Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Biochips Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biochips Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biochips Market Segmentation

• 9.1. Global Biochips Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays
• 9.2. Global Biochips Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microarrays, Microfluidics
• 9.3. Global Biochips Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications
• 9.4. Global Biochips Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users
• 9.5. Global Biochips Market, Sub-Segmentation Of Deoxyribonucleic Acid (DNA) Chips, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gene Expression Chips, SNP (Single Nucleotide Polymorphism) Chips, DNA Microarrays
• 9.6. Global Biochips Market, Sub-Segmentation Of Protein Chips, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antibody Arrays, Protein Microarrays, Peptide Arrays
• 9.7. Global Biochips Market, Sub-Segmentation Of Lab-On-Chip, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microfluidic Devices, Biosensors
• 9.8. Global Biochips Market, Sub-Segmentation Of Tissue Arrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tumor Tissue Arrays, Normal Tissue Arrays
• 9.9. Global Biochips Market, Sub-Segmentation Of Cell Arrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cell-Based Biochips, Cell Signaling Arrays

10. Biochips Market Regional And Country Analysis

• 10.1. Global Biochips Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Biochips Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biochips Market

• 11.1. Asia-Pacific Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biochips Market

• 12.1. China Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biochips Market

• 13.1. India Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biochips Market

• 14.1. Japan Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biochips Market

• 15.1. Australia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biochips Market

• 16.1. Indonesia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biochips Market

• 17.1. South Korea Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biochips Market

• 18.1. Taiwan Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biochips Market

• 19.1. South East Asia Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biochips Market

• 20.1. Western Europe Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biochips Market

• 21.1. UK Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biochips Market

• 22.1. Germany Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biochips Market

• 23.1. France Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biochips Market

• 24.1. Italy Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biochips Market

• 25.1. Spain Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biochips Market

• 26.1. Eastern Europe Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biochips Market

• 27.1. Russia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biochips Market

• 28.1. North America Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biochips Market

• 29.1. USA Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biochips Market

• 30.1. Canada Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biochips Market

• 31.1. South America Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biochips Market

• 32.1. Brazil Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biochips Market

• 33.1. Middle East Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biochips Market

• 34.1. Africa Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biochips Market Regulatory and Investment Landscape

36. Biochips Market Competitive Landscape And Company Profiles

• 36.1. Biochips Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Biochips Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Biochips Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Roche Diagnostics International Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Biochips Market Other Major And Innovative Companies

• Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., NanoCellect Biomedical Inc., Dolomite Microfluidics

38. Global Biochips Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biochips Market

40. Biochips Market High Potential Countries, Segments and Strategies

• 40.1 Biochips Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Biochips Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Biochips Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer